April2024_RDCOS Data Catalog 1

April2024_RDCOS Data Catalog 1
In January 2023, FDA announced that it would like to work with Congress to craft a legislative approach to the regulation of CBD products.
This report was ordered by the Oklahoma Medical Marijuana Authority (OMMA) to examine the supply chain and demand of the medical cannabis market…
The Cannabis Legalization and Public Health Outcomes: Part I study is one of the largest studies to date on cannabis legalization and cannabis use. The study analyzes and compares survey data from approximately 5,000 U.S. residents across 25 U.S. states with varying...
Overview Illicit Market, CUD, and Cannabis-Related Hospitalizations Few scientific studies examine the prevalence of hospitalization cases in cannabis users, even though it is a common reason given against cannabis legalization. Evidence suggests that hospitalization...